M
Miia Kivipelto
Researcher at Karolinska University Hospital
Publications - 516
Citations - 70761
Miia Kivipelto is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Dementia & Population. The author has an hindex of 91, co-authored 447 publications receiving 58328 citations. Previous affiliations of Miia Kivipelto include National Institute for Health and Welfare & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Advances in the prevention of Alzheimer's Disease.
TL;DR: The evidence on risk and protective factors from observational studies, ongoing lifestyle-related and pharmacological randomized controlled trials (RCTs), as well as future directions for dementia and AD prevention are summarized and discussed.
Journal Article
EDUCATION AND DEMENTIA : WHAT LIES BEHIND THE ASSOCIATION? Authors' reply
Timo E. Strandberp,Kaisu H. Pitkälä,Pentti J. Tienari,Reijo S. Tilvis,Tiia Ngandu,Miia Kivipelto +5 more
TL;DR: In this study, only one of 18 patients with seizures on cEEG showed a definite clinical correlate, despite the fact that most also had continuous digital video recordings, which confirms earlier studies from this center and others.
Journal ArticleDOI
Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)
Ruth Stephen,Yawu Liu,Tiia Ngandu,Tiia Ngandu,Riitta Antikainen,Riitta Antikainen,Juha Hulkkonen,Juha Koikkalainen,Nina Kemppainen,Nina Kemppainen,Jyrki Lötjönen,Esko Levälahti,Riitta Parkkola,Pauliina Pippola,Juha O. Rinne,Juha O. Rinne,Timo E. Strandberg,Timo E. Strandberg,Jaakko Tuomilehto,Ritva Vanninen,Miia Kivipelto,Hilkka Soininen,Alina Solomon,Alina Solomon +23 more
TL;DR: The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) as mentioned in this paper was a multicenter randomized controlled trial that reported beneficial effects on cognition for a 2-year multimodal intervention (diet, exercise, cognitive training, vascular risk monitoring) versus control (general health advice).
Journal ArticleDOI
Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders.
Marjan Shafaati,Alina Solomon,Alina Solomon,Miia Kivipelto,Miia Kivipelto,Ingemar Björkhem,Valerio Leoni +6 more
TL;DR: A significant correlation is demonstrated here between levels of apoE and 24S-hydroxycholesterol in cerebrospinal fluid from patients with Alzheimer's disease and patients with mild cognitive impairment and such a correlation was not found in control patients.
Journal ArticleDOI
Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer's disease: a population-based cardiovascular risk factors, aging and dementia study
Minna Rusanen,Suvi Rovio,Tiia Ngandu,Aulikki Nissinen,J. Tuomilehto,Hilkka Soininen,Miia Kivipelto +6 more
TL;DR: Midlife smoking was associated with an increased risk of dementia and AD later in life only among those individuals carrying the APOE Ε4 allele, suggesting that the association between smoking and AD may be complex and vary according to genotype.